Bank of Montreal’s Petros Pharmaceuticals PTPI Stock Holding History

Bank of Montreal’s Portfolio PTPI Stock Details PTPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-400	Closed	-$27.4K	–	4137
2023 Q2	$27.4K	Buy	+400	New	+$31.2K	﹤0.01%	3691

Other funds holding PTPI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's PTPI Position: Q3 2023 in Review

Bank of Montreal sold out of Petros Pharmaceuticals (PTPI) in Q3 2023, closing a stake of 400 shares — an estimated $27.4K sold.

Bank of Montreal first reported a position in PTPI in Q2 2023 and held it in 1 quarter. The position peaked at $27.4K in Q2 2023. 11 funds tracked by Wall St. Rank hold PTPI as of Q3 2023.

Bank of Montreal reported no remaining Petros Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Bank of Montreal sold 400 Petros Pharmaceuticals shares in Q3 2023, an estimated $27.4K.
Bank of Montreal first reported a position in Petros Pharmaceuticals in Q2 2023 and held it in 1 quarter.
Bank of Montreal's Petros Pharmaceuticals position peaked at $27.4K in Q2 2023.
11 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.